Abramson Cancer Center — Philadelphia, Pennsylvania

Abramson Cancer Center is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Clinical Trials Trust Score: 25/100 (FAILING). This profile has not yet been claimed by the site owner.

Abramson Cancer Center has participated in 34 clinical trials with 15 currently active.

Therapeutic areas: Malignant Solid Neoplasm, Metastatic Breast Cancer, Lobular Breast Carcinoma.

Sponsors: Roswell Park Cancer Institute, University of California, San Francisco, Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Philadelphia

Browse all research sites in Pennsylvania · View every site in Philadelphia

Sponsor Feasibility Report

Trust Score: 25/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Abramson Cancer Center?

Abramson Cancer Center has a Crixeo Trust Score of 25/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Abramson Cancer Center conducted?

Abramson Cancer Center has 34 clinical trials on record, with 15 currently active. Their work covers Malignant Solid Neoplasm, Metastatic Breast Cancer, Lobular Breast Carcinoma.

Is Abramson Cancer Center accredited by Crixeo Clinical Trials?

Abramson Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Abramson Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.